These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23053029)

  • 1. [Age and comorbidity in early prostate cancer].
    Fröhner M; Wirth MP
    Urologe A; 2012 Oct; 51(10):1356-61. PubMed ID: 23053029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of radical prostatectomy for patients older than 70 years].
    Thomas C; Roos FC; Thüroff JW
    Urologe A; 2012 Oct; 51(10):1362-7. PubMed ID: 23053030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Approach to prostate cancer in men older than 75 years: active or passive?].
    Spahn M; Haeni K
    Urologe A; 2012 Oct; 51(10):1368-74. PubMed ID: 23053031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survival score for patients with metastatic spinal cord compression from prostate cancer.
    Rades D; Douglas S; Veninga T; Bajrovic A; Stalpers LJ; Hoskin PJ; Rudat V; Schild SE
    Strahlenther Onkol; 2012 Sep; 188(9):802-6. PubMed ID: 22526228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which comorbidity classification best fits elderly candidates for radical prostatectomy?
    Froehner M; Hentschel C; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    Urol Oncol; 2013 May; 31(4):461-7. PubMed ID: 21498089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.
    Hall WH; Jani AB; Ryu JK; Narayan S; Vijayakumar S
    Prostate Cancer Prostatic Dis; 2005; 8(1):22-30. PubMed ID: 15700051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk.
    Lunardi P; Ploussard G; Grosclaude P; Roumiguié M; Soulié M; Beauval JB; Malavaud B
    World J Urol; 2017 Apr; 35(4):587-593. PubMed ID: 27443847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.
    Daskivich TJ; Thomas IC; Luu M; Shelton JB; Makarov DV; Skolarus TA; Leppert JT
    J Urol; 2019 Sep; 202(3):518-524. PubMed ID: 31009286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of comorbidity and age in radical prostatectomy].
    Wirth M; Fröhner M
    Urologe A; 2004 Aug; 43(8):935-41. PubMed ID: 15278203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an Age-adjusted Prostate Cancer-Specific Comorbidity Index.
    Froehner M; Koch R; Hübler M; Wirth MP
    Eur Urol; 2016 May; 69(5):764-6. PubMed ID: 26558839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial.
    Giacalone NJ; Wu J; Chen MH; Renshaw A; Loffredo M; Kantoff PW; D'Amico AV
    J Clin Oncol; 2016 Nov; 34(31):3781-3786. PubMed ID: 27601545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of age and comorbidity on survival and toxicity of irradiated prostate cancer patients].
    Ferrer González F; Casas Duran F; Biete Solà A
    Med Clin (Barc); 2005 Jun; 125(4):121-6. PubMed ID: 15989851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication.
    Gulati R; Psutka SP; Etzioni R
    J Urol; 2019 Nov; 202(5):936-943. PubMed ID: 31112106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of co-morbidity on life expectancy among men with localized prostate cancer.
    Albertsen PC; Fryback DG; Storer BE; Kolon TF; Fine J
    J Urol; 1996 Jul; 156(1):127-32. PubMed ID: 8648773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.
    Sohlberg EM; Thomas IC; Yang J; Kapphahn K; Daskivich TJ; Skolarus TA; Shelton JB; Makarov DV; Bergman J; Bang CK; Goldstein MK; Wagner TH; Brooks JD; Desai M; Leppert JT
    Urol Oncol; 2020 Sep; 38(9):734.e1-734.e10. PubMed ID: 32674954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an optimal comorbidity index for prostate cancer?
    Alibhai SM; Leach M; Tomlinson GA; Krahn MD; Fleshner NE; Naglie G
    Cancer; 2008 Mar; 112(5):1043-50. PubMed ID: 18286512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does cigarette smoking influence the survival of patients with prostate cancer?].
    Jäger T; Eisenhardt A; Rübben H; Lümmen G
    Urologe A; 2007 Apr; 46(4):397-400. PubMed ID: 17221247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis.
    Löppenberg B; Dalela D; Karabon P; Sood A; Sammon JD; Meyer CP; Sun M; Noldus J; Peabody JO; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 Jul; 72(1):14-19. PubMed ID: 27174537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.